GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Urologix, Inc. (ULGX) [hlAlert]

Rating:
Buy ULGX
down 96.11 %

Urologix, Inc. (ULGX) rated Buy with price target $2 by Dougherty & Company

Posted on: Tuesday,  Jul 17, 2012  12:25 PM ET by Dougherty & Company

Dougherty & Company rated Buy Urologix, Inc. (OTCBB: ULGX) on 07/17/2012, when the stock price was $0.90.
Since then, Urologix, Inc. has lost 96.11% as of 08/27/2015's recent price of $0.04.
If you would have followed this Dougherty & Company 's recommendation on ULGX, you would have lost 96.11% of your investment in 1136 days.

Urologix, Inc., based in Minneapolis, develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders. The Company has developed and offers non-surgical, anesthesia-free, catheter-based treatments that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia, a condition that affects more than twenty three million men worldwide. Urologix' products include the CoolWave, Targis and Prostatron control units and the Cooled ThermoCath, Targis and Prostaprobe catheter families. Additionally, Urologix is currently developing CoolMax, its next generation microwave catheter for in-office benign prostatic hyperplasia treatment. All of Urologix' products utilize Cooled ThermoTherapy targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort and provide safe, effective, lasting relief of the symptoms of benign prostatic hyperplasia.

Team The research group is composed of five senior analysts and two associate analysts. The senior analysts collectively have 44 years of securities industry experience, and include 3 MBA's, 2 CPA's, 2 PE's (professional engineer), a CFA and a CMA. The team has come together out of a passion for overlooked or misunderstood investment opportunities – generally in smaller-cap companies – and a love of in-depth research, with special emphasis on independent information sources and innovative thinking. Coverage Our research coverage is idea driven and balances the twin demands of opportunism for flexibility and universe consistency for maximization of information sources. Current sub-sectors of interest include: * Specialty retail * Internet security * Internet media * Auto-identification and data capture (AIDC & RFID) * Mobile computing * Specialty manufacturing * Chronic care management * Outpatient services * Medical devices * Healthcare IT
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/17/2012 12:25 PM Buy
None
0.90 2.00
as of 12/31/2012
1 Week down  -4.16 %
1 Month up  9.52 %
3 Months down  -9.21 %
1 YTD down  -23.33 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy